RAPT Therapeutics to Participate in the SVB Securities Global Biopharma Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023 at 1:40 p.m. Eastern Time.

To access the live webcast or subsequent archived recording of the discussion, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

About RAPT Therapeutics, Inc.

RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. Utilizing its proprietary discovery and development engine, the Company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. RAPT has discovered and advanced two unique drug candidates, RPT193 and FLX475, each targeting C-C motif chemokine receptor 4 (CCR4), for the treatment of inflammation and cancer, respectively. The Company is also pursuing a range of targets that are in the discovery stage of development.

RAPT Media Contact:
Aljanae Reynolds
areynolds@wheelhouselsa.com

RAPT Investor Contact:
Sylvia Wheeler
swheeler@wheelhouselsa.com

Staff

Recent Posts

As Pilgrims Arrive in Makkah, Saudi Arabia Rolls Out Massive Operation to Safeguard Health

Massive health operation for world's largest religious gathering with 111,400 health services already delivered. 111,400…

3 hours ago

Mark A. Davis, MD, MS Joins X Boson Inc. Board to Drive Strategy, Innovation, and Healthcare System Integration in AI-Powered Medication Management

Healthcare executive and physician brings decades of healthcare leadership, growth, and operational success to scale…

3 hours ago

Leaders from Sharp HealthCare and MCG Discuss AI-Driven Utilization Management Success at CMSA 2025

Care management experts will discuss the benefits of leveraging new technologies to reduce hospital administrative…

3 hours ago

CaringBridge and DoorDash Partner for Two-Day Fundraising Match to Support Family Caregivers

BLOOMINGTON, Minn. and SAN FRANCISCO, June 5, 2025 /PRNewswire/ -- CaringBridge, the nonprofit health communication platform,…

3 hours ago

HealthVerity and Medeloop Announce Strategic Partnership to Enhance Real-World Evidence Insights with AI-Driven Analytics

PHILADELPHIA and MENLO PARK, Calif., June 5, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world…

3 hours ago